Abstract
Since bone resorption and formation occur repeatedly within the functional units referred to as bone multicellular units, uncoupling between bone resorption by osteoclasts and bone formation by osteoblasts causes an absolute decrease in the amount of bone in osteoporosis. For that reason, it is necessary to fully understand the remodeling characteristics of bone grafts by osteoclasts and osteoblasts to high-bioactive materials. We have, therefore, prepared hydroxyapatite (HAp) and collagen composites to improve bioaffinity through the interaction between materials and bone cells for applications in drug delivery devices. Apatite/collagen composite cements could be applied to artificial bone drug delivery systems without drug inactivation caused by high pressure and those that exhibit long-term slow drug release in vitro and high in vivo biocompatibility in osteoporosis model rats. On the other hand, geometrical structure of pores in implantable artificial bone has been proven successful in bone generation, since bone-related cells can be cultured more readily in interconnected porous materials, such as coral-modified implant made by calcium phosphate. Interconnective pores in coral-like material are therapeutically effective in bone regeneration within the body through the introduction of bone cells and capitally blood vessels as a scaffold for bone cells to spread and proliferate. The interconnective porous biomaterials are, therefore, developed based on self-setting apatite/collagen composite cement as materials with enhanced biocompatibility and drug delivery capability. Since the drug release rate from the composite device could be controlled by various geometrical factors, the relationship between drug-release rate and number of the macropores was investigated by in vitro dissolution test. Bioaffinity of the interconnective porous biomaterials of apatite/collagen composite cement was examined in rat models using X-ray computed tomography.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Baron R, Vignery A, Horowitz M (1987) Lymphocytes, macrophages and the regulation of bone remodeling. In: Peck WA (ed) Bone and mineral research. Annual Elsevier, Amsterdam, pp 209–279
Aoki H (1994) Medical applications of hydroxyapatite. Ishiyaku EuroAmerica Inc., Tokyo, p 156
Miyamoto Y, Ishikawa K, Takechi M, Toh T, Yuasa T, Nagayama M, Suzuki K (1998) Basic properties of calcium phosphate cement containing atelocollagen in its liquid or powder phases. Biomaterials 19:707–715
Kikuchi M, Itoh S, Ichinose S, Shinomiya K, Tanaka J (2001) Self-organization mechanism in a bone-like hydroxyapatite/collagen nanocomposite synthesized in vitro and its biological reaction in vivo. Biomaterials 22:1705–1711
Itoh S, Kikuchi M, Koyama Y, Takakuda K, Shinomiya K, Tanaka J (2002) Development of an artificial vertebral body using a novel biomaterial, hydroxyapatite/collagen composite. Biomaterials 23:3919–3926
John A, Hong L, Ikada Y, Tabata Y (2001) A trial to prepare biodegradable collagen-hydroxyapatite composites for bone repair. J Biomater Sci Polym 12:89–705
Otsuka M, Kuninaga T, Otsuka K, Higuchi WI (2006) Effect of nanostructure on biodegradation behaviors of self-setting apatite/collagen composite cements containing vitamin K2 in rats. J Biomed Mater Res B App Biomater 79B:176–184
Chhettry A, Wang Z, Hsu J, Fox JL, Baig AA, Barry AM, Zhuang H, Otsuka M, Higuchi WI (1999) Metastable equilibrium solubility distribution of carbonated apatite as function of solution composition. J Colloid Int Sci 218:57–67
Shiraki M, Shiraki Y, Aoki C, Miura M (2000) Vitamin K2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res 15(3):515–521
Shiomi S, Nishiguchi S, Kubo S, Tamori A, Habu D, Takeda T, Ochi H (2002) Vitamin K2 (menatetrenone) for bone loss in patients with cirrhosis of the liver. Am J Gastroenterol 97(4):978–981
Delloye C, Cnockaert N, Cornu O (2003) Current concepts review, bone substitutes, an overview. Acta Orthop Belg 69:1–8
Miyai T, Ito A, Tamazawa G, Matsuno T, Sogo Y, Nakamura C, Yamazaki A, Satoh T (2008) Antibiotic-loaded poly-ε-caprolactone and porous β-tricalcium phosphate composite for treating osteomyelitis. Biomaterials 29:350–358
Kuboki Y, Jin Q, Kikuchi M, Mamood J, Takita H (2002) Geometry of artificial ECM: sizes of pores controlling phenotype expression in BMP-induced osteogenesis and chondrogenesis. Connect Tissue Res 43:529–534
Otsuka M, Nakagawa H, Otsuka K, Ito A, Higuchi WI (2013) Effect of geometrical structure on the in vivo quality change of a three-dimensionally perforated porous bone cell scaffold made of apatite/collagen composite. J Biomed Mater Res B Appl Biomater 101B(2):338–345
Otsuka M, Nakagawa H, Ito A, Higuchi WI (2010) Effect of geometrical structure on drug release rate of a three-dimensionally perforated porous apatite/collagen composite cement. J Pharm Sci 99(1):286–292
Otsuka M, Hirano R (2011) Bone cell activity responsive drug release from biodegradable apatite/collagen nano-composite cements, – in-vitro dissolution medium responsive vitamin K2 release colloids and surfaces B. Biointerfaces 85(2):338–342
Väänänen HK, Zhao H, Mulari M, Halleen JM (2000) The cell biology of osteoclast function. J Cell Sci 113(Pt 3):377–381
Acknowledgments
The author would like to deeply thank Prof. William I. Higuchi, University of Utah for his great leadership to our international collaboration research. The author thanks Professor Hiroyuki Ohshima, Tokyo University of Science, and Dr. Atsuo Ito, NIAIST, for their scientific advice. The author thanks Mr. Ryuhei Hirano, Mr. Hideyuki Hamada, Mr. Hidenori Nakagawa, and Mr. Tomoaki Kuninaga for their experimental works.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Otsuka, M. (2014). Development of Skeletal Drug Delivery System Based on Apatite/Collagen Composite Cement. In: Ben-Nissan, B. (eds) Advances in Calcium Phosphate Biomaterials. Springer Series in Biomaterials Science and Engineering, vol 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-53980-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-53980-0_11
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-53979-4
Online ISBN: 978-3-642-53980-0
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)